| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/03/2008 | CN100415225C Novel use of peptide class of compound for treating non-neuropathic inflammatory pain |
| 09/03/2008 | CN100415222C Methods of using and compositions comprising dopamine reuptake inhibitors |
| 09/03/2008 | CN100415216C Timed dual release dosage forms comprising short acting hypnotic or salt thereof |
| 09/02/2008 | US7420069 Crystalline composition containing escitalopram |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7420003 Compounds and a novel process for their preparation |
| 09/02/2008 | US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues |
| 09/02/2008 | US7419999 Gamma lactams as prostaglandin agonists and use thereof |
| 09/02/2008 | US7419998 Therapeutic methods and compositions involving isoflavones |
| 09/02/2008 | US7419994 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds |
| 09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 09/02/2008 | US7419985 reuptake of norephinephrine, dopamine, and serotonin inhibitor; furo-, pyrrolo-, and thienyl-tetrahydroisoquinolines, e.g. 2 methyl 4 phenyl 1,2,3,4,8,9 hexahydro furo[2,3 h]isoquinoline; antidepressant, anxiolytic agent; neurological and psychological disorders |
| 09/02/2008 | US7419977 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2- alpha ]quinoline-2-carbonyl)morpholine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives |
| 09/02/2008 | US7419956 Isolated physiologically active peptide and use thereof |
| 09/02/2008 | US7419814 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | US7419793 Flea octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/02/2008 | US7419790 Sodium-independent transporter carrying acidic amino acid and its gene |
| 09/02/2008 | US7419686 For preventing oral abuse of an oral opioid formulation; provides a negative, "aversive" experience when a large amount of the opioid, e.g., about 2-3 times the usually prescribed dose, is taken by or administered to a physically dependent subject |
| 09/02/2008 | US7419676 Activatable recombinant neurotoxins |
| 09/02/2008 | US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant |
| 09/02/2008 | CA2466728C Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
| 09/02/2008 | CA2461757C Nicotine formulations comprising chocolate and use thereof |
| 09/02/2008 | CA2461517C Nicotine formulations comprising cocoa and use thereof |
| 09/02/2008 | CA2440468C Pregabalin lactose conjugates |
| 09/02/2008 | CA2411412C Indole derivatives useful for the treatment of cns disorders |
| 09/02/2008 | CA2395037C The use of scopolamine salts |
| 09/02/2008 | CA2386813C Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring |
| 09/02/2008 | CA2306881C Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 09/02/2008 | CA2306350C Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 09/02/2008 | CA2160447C Amino(thio)ether derivatives |
| 08/28/2008 | WO2008103636A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 08/28/2008 | WO2008103472A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 08/28/2008 | WO2008103461A2 Solid forms comprising (-) o-desmethylvenlafaxine and uses thereof |
| 08/28/2008 | WO2008103351A2 Heterocyclic aspartyl protease inhibitors |
| 08/28/2008 | WO2008103185A2 Substituted carboxamides as group i metabotropic receptor antagonists |
| 08/28/2008 | WO2008102859A1 Agent for prevention and/or treatment of anxiety disorders |
| 08/28/2008 | WO2008102790A1 Pharmaceutical composition for prevention or treatment of disease associated with tear reduction |
| 08/28/2008 | WO2008102777A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | WO2008102749A1 Heterocyclic compound |
| 08/28/2008 | WO2008102716A1 Agent for treatment of adhd-related diseases |
| 08/28/2008 | WO2008101953A1 Compounds of formula (i) as serine protease inhibitors |
| 08/28/2008 | WO2008101824A1 Imidazo[1',5':1,6] pyrido[3,4-b]indoles derivatives and therapeutical use thereof |
| 08/28/2008 | WO2008101693A2 Cosmetic and pharmaceutical applications of n-acylated amino acids and structurally related compounds |
| 08/28/2008 | WO2008101692A2 Cosmetic and pharmaceutical applications of n-acetylhydroxyproline |
| 08/28/2008 | WO2008101660A1 Spirocyclic cyclohexane derivatives |
| 08/28/2008 | WO2008101659A1 Spirocyclic cyclohexane derivatives |
| 08/28/2008 | WO2008101412A1 The use of epimedium flavones and effective components thereof for the preparation of medicaments of promoting proliferations and differentiations of nerve cells |
| 08/28/2008 | WO2008101266A1 Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6h-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof |
| 08/28/2008 | WO2008081399A3 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 08/28/2008 | WO2008080120A3 3-amino chromane derivatives |
| 08/28/2008 | WO2008079683A3 N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain |
| 08/28/2008 | WO2008070305A3 1, 5-diphenyl-3-pyridinylamino-1, 5-dihydropyrrolidin-2-one as cbl' receptor modulator |
| 08/28/2008 | WO2008065666A3 Uses of incensole, incensole acetate and derivatives thereof |
| 08/28/2008 | WO2008057496A3 Method for treating delirium |
| 08/28/2008 | WO2008019823A3 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 08/28/2008 | WO2007134136A3 Neurogenesis by modulating angiotensin |
| 08/28/2008 | WO2007073497A3 Calcium channel antagonists |
| 08/28/2008 | US20080207902 Phosphodiesterase inhibitors; side effect reduction |
| 08/28/2008 | US20080207763 Synergistic mixture of analgesics and endothelin antagonist; fever therapy |
| 08/28/2008 | US20080207761 Pharmaceutical formulations of modafinil |
| 08/28/2008 | US20080207757 Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same |
| 08/28/2008 | US20080207755 Administering 3-aminomethyl-5-methyloctanoic acid; syndrome; analgesics; urogenital system pain |
| 08/28/2008 | US20080207748 Vitamin c preparation |
| 08/28/2008 | US20080207731 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom |
| 08/28/2008 | US20080207730 Methods of using (+)-2-[1-(3-Ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione |
| 08/28/2008 | US20080207719 Treatment of Epilepsy |
| 08/28/2008 | US20080207716 Formulations and Dosing Regiment for Ppar-Alpha Modulators |
| 08/28/2008 | US20080207715 Novel Inhibitors of Glutaminyl Cyclase |
| 08/28/2008 | US20080207702 Use of Quaternary Pyridinium Salts as Vasoprotective Agents |
| 08/28/2008 | US20080207697 Nervous system connecting diseases such as autism |
| 08/28/2008 | US20080207696 Phenacyl 2-Hydroxy-3-Diaminoalkanes |
| 08/28/2008 | US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 08/28/2008 | US20080207668 Pharmaceutical compositions of hydromorphone for prevention of overdose or abuse |
| 08/28/2008 | US20080207666 Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
| 08/28/2008 | US20080207660 Antiallergens; antiinflammatory agents; drug abuse; cognition activators; psychological disorders; side effect reduction; aryl and heteroaryl pyrazole compounds |
| 08/28/2008 | US20080207655 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 08/28/2008 | US20080207649 Method of treating brain ischemia |
| 08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
| 08/28/2008 | US20080207637 Controlling triglyceride concentration; central nervous system disorders; psychological disorders; eating disordes; drug abuse; anticancer agents |
| 08/28/2008 | US20080207633 Conjugated to polyoxyethylene glycol; analgesics; antidiabetic agents; anticancer agents; sleep disorders; antidepressants; anxiolytic agents |
| 08/28/2008 | US20080207631 Administering adatanserin; analgesics; Parkinson's disease; amyotrophic lateral sclerosis; vision defects; antiepileptic agents; antihypoxic agents |
| 08/28/2008 | US20080207628 Methods of preventing and reducing the severity of stress-associated conditions |
| 08/28/2008 | US20080207627 Methods of preventing and reducing the severity of stress-associated conditions |
| 08/28/2008 | US20080207619 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 08/28/2008 | US20080207612 Analgesics; pain management |
| 08/28/2008 | US20080207611 Anticancer agents; kinase inhibitors; viricides; antiinflammatory agents; immunotherapy; metabolism disorders |
| 08/28/2008 | US20080207610 Aldh-2 inhibitors in the treatment of addiction |
| 08/28/2008 | US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects |
| 08/28/2008 | US20080207604 Dtection compound that moderated tau-tau protein association; Alzheimer's disease; administering methylene blue |
| 08/28/2008 | US20080207603 Methods of Chemical Synthesis and Purification of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc) |
| 08/28/2008 | US20080207602 Succinoylamino benzodiazepines as inhibitors of abeta protein production |
| 08/28/2008 | US20080207601 Methods of and Compositions For the Prevention of Anxiety, Substance Abuse, and Dependence |
| 08/28/2008 | US20080207600 Pharmaceutical Combination for the Treatment of Cns Functional Disorders |
| 08/28/2008 | US20080207599 Use of Selective Chloride Channel Modulators to Treat Methamphetamine Abuse |
| 08/28/2008 | US20080207598 Indole derivatives |
| 08/28/2008 | US20080207576 Substituted sapogenins and their use |
| 08/28/2008 | US20080207565 Use of bisphosphonates for pain treatment |
| 08/28/2008 | US20080207557 A time-release formulation of a water-soluble derivative having the fatty acid moiety removed and an antiinflammatory agent; opoid resistant neuropathic pain, amputation pain or neuralgia; |
| 08/28/2008 | US20080207552 Decoy compositions for treating and preventing brain diseases and disorders |